Published in Anal Biochem on April 01, 1985
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood (1994) 6.47
Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet (1998) 6.04
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ (2001) 4.66
Comparison of the ultrastructure of several rickettsiae, ornithosis virus, and Mycoplasma in tissue culture. J Bacteriol (1965) 4.48
Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med (2001) 4.19
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (2001) 3.64
Accuracy of clinical assessment of deep-vein thrombosis. Lancet (1995) 3.45
Primary infantile glaucoma (congenital glaucoma). Surv Ophthalmol (1983) 2.99
The mode of progressive disc cupping in ocular hypertension and glaucoma. Arch Ophthalmol (1980) 2.92
Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol (1974) 2.91
Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee. Am J Ophthalmol (1995) 2.88
Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol (2001) 2.84
Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ (2014) 2.80
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood (1991) 2.54
Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49
Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost (2010) 2.43
Linking structure and function in glaucoma. Prog Retin Eye Res (2010) 2.43
Immune-related disease and normal-tension glaucoma. A case-control study. Arch Ophthalmol (1992) 2.42
Estimates of young children's time with television: a methodological comparison of parent reports with time-lapse video home observation. Child Dev (1985) 2.38
Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med (1997) 2.28
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1998) 2.17
D-dimer testing is useful to exclude deep vein thrombosis in elderly outpatients. J Thromb Haemost (2008) 2.08
Clinical recognition of glaucomatous cupping. Am J Ophthalmol (1973) 2.08
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation (2004) 2.05
The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest Ophthalmol (1976) 1.97
An evaluation of the API-STREP identification system. Med Lab Sci (1981) 1.97
Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med (2001) 1.82
5-fluorouracil and glaucoma filtering surgery. II. A pilot study. Ophthalmology (1984) 1.81
An orbital period of 0.94 days for the hot-Jupiter planet WASP-18b. Nature (2009) 1.79
Comparison of analytic algorithms for detecting glaucomatous visual field loss. Arch Ophthalmol (1991) 1.77
Sucrose synthetase from Phaseolus aureus seedlings. J Biol Chem (1970) 1.77
The development of the trabecular meshwork and its abnormality in primary infantile glaucoma. Trans Am Ophthalmol Soc (1981) 1.76
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med (1998) 1.76
The influence of position on intraocular pressure. Invest Ophthalmol (1973) 1.75
The course of axons through the retina and optic nerve head. Arch Ophthalmol (1979) 1.74
Trabecular surgery. Arch Ophthalmol (1974) 1.71
Sialic acid transferases and sialic acid levels in normal and transformed cells. Biochemistry (1970) 1.64
Ultrastructure of human and monkey lamina cribrosa and optic nerve head. Arch Ophthalmol (1969) 1.60
Ultrastructural and histochemical observations of optic nerve gliomas. Arch Ophthalmol (1970) 1.59
Ultrastructure of intraorbital portion of human and monkey optic nerve. Arch Ophthalmol (1969) 1.58
Modification of Sindbis virus glycoprotein by host-specified glycosyl transferases. J Virol (1971) 1.58
Effect of elevated intraocular pressure on blood flow. Occurrence in cat optic nerve head studied with iodoantipyrine I 125. Arch Ophthalmol (1983) 1.58
A method of preparing peripheral leucocytes for electron microscopy. J Ultrastruct Res (1965) 1.57
Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies. Am J Ophthalmol (1994) 1.54
Trabeculotomy compared to goniotomy for glaucoma in children. Ophthalmology (1983) 1.53
Distribution of axonal transport blockade by acute intraocular pressure elevation in the primate optic nerve head. Invest Ophthalmol Vis Sci (1977) 1.51
Pseudo-loss of fixation in automated perimetry. Ophthalmology (1991) 1.51
Clinical histologic correlation of human peripapillary anatomy. Ophthalmology (1989) 1.51
Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma). Arch Ophthalmol (1988) 1.50
The relationship between modifiable health risks and health care expenditures. An analysis of the multi-employer HERO health risk and cost database. J Occup Environ Med (1998) 1.50
Ultrastructure of normal and leukemic leukocytes in human peripheral blood. J Ultrastruct Res (1966) 1.47
Early foveal involvement and generalized depression of the visual field in glaucoma. Arch Ophthalmol (1984) 1.45
GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J Neurosci (1995) 1.45
Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol (1998) 1.41
Mechanics of the healed meniscus in a canine model. Am J Sports Med (1989) 1.39
Pulmonary artery sarcoma mimicking pulmonary embolism: successful surgical intervention. Ann Thorac Surg (1996) 1.38
Contact-inhibited revertant cell lines isolated from SV40-transformed cells. I. Biologic, virologic, and chemical properties. J Cell Biol (1971) 1.37
Nonglaucomatous excavation of the optic disc. Arch Ophthalmol (1980) 1.37
Dynamic thermodynamic resolution: control of enantioselectivity through diastereomeric equilibration. Acc Chem Res (2000) 1.33
Dethecting glaucomatous damage with the Friedmann analyzer compared with te Goldmann perimeter and evaluation of stereoscopic photographs of the optic disk. Am J Ophthalmol (1983) 1.33
Blockade of rapid axonal transport. Effect of intraocular pressure elevation in primate optic nerve. Arch Ophthalmol (1979) 1.33
Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol (1993) 1.32
The management of elevated intraocular pressure with normal optic discs and visual fields. I. Therapeutic approach based on high risk factors. Surv Ophthalmol (1977) 1.31
Autoregulation of human optic nerve head circulation in response to increased intraocular pressure. Exp Eye Res (1997) 1.28
Form and content: looking at visual features of television. Dev Psychol (1999) 1.24
Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. Invest Ophthalmol Vis Sci (1994) 1.24
Electron microscopic studies of Mycoplasma (PPLO strain 880) in artificial medium and in tissue culture. J Natl Cancer Inst (1966) 1.23
Retrograde pulmonary embolectomy by flushing of the pulmonary veins. Ann Thorac Surg (1995) 1.22
Retina and optic nerve after posterior ciliary artery occlusion. An experimental study in squirrel monkeys. Arch Ophthalmol (1974) 1.20
ltrastructure of meningeal sheaths. Normal human and monkey optic nerves. Arch Ophthalmol (1969) 1.19
The configuration of peripapillary tissue in unilateral glaucoma. Arch Ophthalmol (1988) 1.18
Vascular supply to the optic nerve of primates. Am J Ophthalmol (1970) 1.18
Deep venous thrombosis: recent advances and optimal investigation with US. Radiology (1999) 1.17
The histology of retinal nerve fiber layer bundles and bundle defects. Arch Ophthalmol (1979) 1.15
Reevaluation of the optic disk vasculature. Am J Ophthalmol (1976) 1.15
Frequent occurrence of hypoplastic optic disks in patients with aniridia. Am J Ophthalmol (1974) 1.14
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost (2004) 1.14
Effect of the intraocular lens on intraocular pressure. Arch Ophthalmol (1976) 1.13
Trabeculectomy in aphakic eyes. Ophthalmology (1984) 1.12
Abnormal scleral collagen in nanophthalmos. An ultrastructural study. Arch Ophthalmol (1991) 1.11
SimpliRED D-dimer can reduce the diagnostic tests in suspected deep vein thrombosis. Lancet (1998) 1.10
Calibration of new high dose rate 192Ir sources. Med Phys (2002) 1.09
Intracranial pressure and ocular hemodynamics. Arch Ophthalmol (1973) 1.07
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost (2005) 1.06
Experimental ocular siderosis in the squirrel monkey. Am J Ophthalmol (1972) 1.06
Descending optic nerve degeneration in primates. Invest Ophthalmol Vis Sci (1977) 1.05
Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. J Immunol (1989) 1.05
Calcium-promoted changes of the human erythrocyte membrane. Involvement of spectrin, transglutaminase, and a membrane-bound protease. J Biol Chem (1977) 1.05
Accommodation of an endocapsular silicone lens (Phaco-Ersatz) in the nonhuman primate. Ophthalmology (1987) 1.04
Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol (1992) 1.03
Glycosyltransferase and sialic acid levels of normal and transformed cells. Biochemistry (1973) 1.03
Cell surface glycolipid and glycoprotein glycosyltransferases of normal and transformed cells. J Biol Chem (1974) 1.02
A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost (2007) 1.02
Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular- weight heparin for the treatment of venous thromboembolism. Haemostasis (2001) 1.01
Cupping of the optic disc in ischemic optic neuropathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol (1978) 1.01
Acquired peripapillary changes and progression in glaucoma. Graefes Arch Clin Exp Ophthalmol (1988) 1.01